Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

A first-of-its-kind antiviral gel may offer the potential to stop papillomavirus (HPV) infection before it causes cancer. ( ...

Genital HPV infections are thought to be responsible for more than 99% of cervical cancers. At least partly because the ...

Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate ...

A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...

US study highlights success story of HPV vaccination A new study published Thursday by researchers at the US Centers for Disease Control and Prevention (CDC) highlights the powerful impact of the ...

Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer ...

The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...